These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 28732161)
1. Elegant pH-Responsive Nanovehicle for Drug Delivery Based on Triazine Dendrimer Modified Magnetic Nanoparticles. Landarani-Isfahani A; Moghadam M; Mohammadi S; Royvaran M; Moshtael-Arani N; Rezaei S; Tangestaninejad S; Mirkhani V; Mohammadpoor-Baltork I Langmuir; 2017 Aug; 33(34):8503-8515. PubMed ID: 28732161 [TBL] [Abstract][Full Text] [Related]
2. Magnetic triazine-based dendrimer as a versatile nanocarrier for efficient antiviral drugs delivery. Ahangarani-Farahani R; Bodaghifard MA; Asadbegi S Sci Rep; 2022 Nov; 12(1):19469. PubMed ID: 36376529 [TBL] [Abstract][Full Text] [Related]
3. Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron. Samra ZQ; Ahmad S; Javeid M; Dar N; Aslam MS; Gull I; Ahmad MM Prep Biochem Biotechnol; 2013; 43(8):781-97. PubMed ID: 23876138 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery. Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe Shen JM; Li XX; Fan LL; Zhou X; Han JM; Jia MK; Wu LF; Zhang XX; Chen J Int J Nanomedicine; 2017; 12():1183-1200. PubMed ID: 28243083 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of pH-sensitive polyamino-ester magneto-dendrimers: Surface functional groups effect on viability of human prostate carcinoma cell lines DU145. Dayyani N; Khoee S; Ramazani A Eur J Med Chem; 2015 Jun; 98():190-202. PubMed ID: 26021708 [TBL] [Abstract][Full Text] [Related]
7. Enzymatic stimuli-responsive methotrexate-conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition. Nosrati H; Mojtahedi A; Danafar H; Kheiri Manjili H J Biomed Mater Res A; 2018 Jun; 106(6):1646-1654. PubMed ID: 29441671 [TBL] [Abstract][Full Text] [Related]
8. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells. Nosrati H; Adibtabar M; Sharafi A; Danafar H; Hamidreza Kheiri M Drug Dev Ind Pharm; 2018 Aug; 44(8):1377-1384. PubMed ID: 29560737 [TBL] [Abstract][Full Text] [Related]
9. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies. Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341 [TBL] [Abstract][Full Text] [Related]
10. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug. Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195 [TBL] [Abstract][Full Text] [Related]
11. Preparation and Evaluation of pH Sensitive Novel Anticancer Drug Carrier Based on Magnetic Chitosan Quartets. Danafar H; Asadi F; Sharafi A; Manjili HK Drug Res (Stuttg); 2019 Sep; 69(9):496-504. PubMed ID: 30912092 [TBL] [Abstract][Full Text] [Related]
12. Dendrimer functionalized magnetic nanoparticles as a promising platform for localized hyperthermia and magnetic resonance imaging diagnosis. Esmaeili E; Khalili M; Sohi AN; Hosseinzadeh S; Taheri B; Soleimani M J Cell Physiol; 2019 Aug; 234(8):12615-12624. PubMed ID: 30536886 [TBL] [Abstract][Full Text] [Related]
13. Simple preparation of maltose-functionalized dendrimer/graphene quantum dots as a pH-sensitive biocompatible carrier for targeted delivery of doxorubicin. Karimi S; Namazi H Int J Biol Macromol; 2020 Aug; 156():648-659. PubMed ID: 32289413 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate anticancer drug delivery to breast cancer cell lines by iron oxide magnetic based nanocarrier. Attari E; Nosrati H; Danafar H; Kheiri Manjili H J Biomed Mater Res A; 2019 Nov; 107(11):2492-2500. PubMed ID: 31298774 [TBL] [Abstract][Full Text] [Related]
15. Glucosamine-Modified Mesoporous Silica-Coated Magnetic Nanoparticles: A "Raisin-Cake"-like Structure as an Efficient Theranostic Platform for Targeted Methotrexate Delivery. Farjadian F; Faghih Z; Fakhimi M; Iranpour P; Mohammadi-Samani S; Doroudian M Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896251 [TBL] [Abstract][Full Text] [Related]
16. Investigation of novel superparamagnetic Ni Qasim M; Asghar K; Dharmapuri G; Das D Nanotechnology; 2017 Sep; 28(36):365101. PubMed ID: 28675377 [TBL] [Abstract][Full Text] [Related]
17. MTX-Loaded Dual Thermoresponsive and pH-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer. Najafipour A; Gharieh A; Fassihi A; Sadeghi-Aliabadi H; Mahdavian AR Mol Pharm; 2021 Jan; 18(1):275-284. PubMed ID: 33300343 [TBL] [Abstract][Full Text] [Related]
18. A Smart Magnetically Active Nanovehicle for on-Demand Targeted Drug Delivery: Where van der Waals Force Balances the Magnetic Interaction. Panja S; Maji S; Maiti TK; Chattopadhyay S ACS Appl Mater Interfaces; 2015 Nov; 7(43):24229-41. PubMed ID: 26458134 [TBL] [Abstract][Full Text] [Related]
19. Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system. Barahuie F; Dorniani D; Saifullah B; Gothai S; Hussein MZ; Pandurangan AK; Arulselvan P; Norhaizan ME Int J Nanomedicine; 2017; 12():2361-2372. PubMed ID: 28392693 [TBL] [Abstract][Full Text] [Related]
20. Magnetic nanoparticles decorated with PEGylated curcumin as dual targeted drug delivery: Synthesis, toxicity and biocompatibility study. Ayubi M; Karimi M; Abdpour S; Rostamizadeh K; Parsa M; Zamani M; Saedi A Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109810. PubMed ID: 31499939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]